TCL Archive Data Presented At Scientific Meetings Can Have Impact On Patient Treatment March 31, 2006
TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors. October 26, 2001
